From the Departments of ∗Nuclear Medicine

†Pharmacy & Pharmacology, Netherlands Cancer Institute, ENETS Center of Excellence, Amsterdam, the Netherlands.

Received for publication September 27, 2023; revision accepted January 7, 2024.

ORCID ID: Daphne Huizing: 0000-0003-1967-8148Maarten L. Donswijk: 0000-0003-2028-9713

Conflicts of interest and sources of funding: none declared.

Michelle W.J. Versleijen, MD, MSc, PhD, Department of Nuclear Medicine, Netherlands Cancer Institute, ENETS Center of Excellence, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. E-mail: [email protected].